US equities
|
NVDA
$233.95
▲+1.34%
MU
$1,074.89
▼-2.05%
TSLA
$370.59
▲+4.65%
SPCX
$158.96
▲+7.35%
SNDK
$1,719.99
▼-3.79%
AMD
$633.91
▲+2.95%
STX
$848.99
▼-10.21%
INTC
$119.33
▼-0.56%
NVDA
$233.95
▲+1.34%
MU
$1,074.89
▼-2.05%
TSLA
$370.59
▲+4.65%
SPCX
$158.96
▲+7.35%
SNDK
$1,719.99
▼-3.79%
AMD
$633.91
▲+2.95%
STX
$848.99
▼-10.21%
INTC
$119.33
▼-0.56%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Schrodinger, Inc. - Common Stock
(NQ:
SDGR
)
30.31
-0.15 (-0.49%)
Delayed Quote
Updated: 4:00 PM EDT, Oct 2, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Schrodinger, Inc. - Common Stock
< Previous
1
2
...
9
10
11
12
13
14
15
16
Next >
Schrödinger to Host Conference Call to Discuss First Quarter 2021 Financial Results
April 27, 2021
From
Schrödinger
Via
Business Wire
Upstart Holdings Has What It Takes to Be a Top AI Company
↗
April 22, 2021
Upstart's AI platform, which is tailored to the lucrative financial sector, makes UPST stock very appealing.
Via
InvestorPlace
Topics
Artificial Intelligence
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
April 16, 2021
From
Schrödinger, Inc.
Via
Business Wire
Schrödinger Reports Preclinical Data on Novel, Selective CDC7 Inhibitors Presented at American Association for Cancer Research Annual Meeting
April 12, 2021
From
Schrödinger
Via
Business Wire
Schrödinger to Participate in BMO BioPharma Spotlight Series: Technology-Enabled Drug Discovery
April 09, 2021
From
Schrödinger
Via
Business Wire
< Previous
1
2
...
9
10
11
12
13
14
15
16
Next >